Toshida K, Itoh S, Iseda N, Izumi T, Bekki Y, Yoshiya S
Ann Surg Oncol. 2024; 31(13):8627-8637.
PMID: 39179864
DOI: 10.1245/s10434-024-16065-3.
Toshida K, Itoh S, Iseda N, Izumi T, Yoshiya S, Toshima T
Cancer Sci. 2023; 115(1):170-183.
PMID: 37878531
PMC: 10823267.
DOI: 10.1111/cas.15981.
Toshida K, Itoh S, Nakayama Y, Tsutsui Y, Kosai-Fujimoto Y, Tomino T
Int J Clin Oncol. 2023; 28(8):1082-1091.
PMID: 37247134
DOI: 10.1007/s10147-023-02358-2.
Tomiyama T, Itoh S, Iseda N, Toshida K, Kosai-Fujimoto Y, Tomino T
Ann Surg Oncol. 2023; 30(6):3378-3389.
PMID: 36641515
DOI: 10.1245/s10434-022-13058-y.
Itoh S, Nagao Y, Morita K, Kurihara T, Tomino T, Kosai-Fujimoto Y
JMA J. 2022; 5(2):169-176.
PMID: 35611230
PMC: 9090533.
DOI: 10.31662/jmaj.2022-0037.
Ferroptosis is induced by lenvatinib through fibroblast growth factor receptor-4 inhibition in hepatocellular carcinoma.
Iseda N, Itoh S, Toshida K, Tomiyama T, Morinaga A, Shimokawa M
Cancer Sci. 2022; 113(7):2272-2287.
PMID: 35466502
PMC: 9277415.
DOI: 10.1111/cas.15378.
Myeloid-derived suppressor cell infiltration is associated with a poor prognosis in patients with hepatocellular carcinoma.
Tomiyama T, Itoh S, Iseda N, Toshida K, Morinaga A, Yugawa K
Oncol Lett. 2022; 23(3):93.
PMID: 35154424
PMC: 8822414.
DOI: 10.3892/ol.2022.13213.
Impact of Nuclear Factor Erythroid 2-Related Factor 2 in Hepatocellular Carcinoma: Cancer Metabolism and Immune Status.
Iseda N, Itoh S, Yoshizumi T, Tomiyama T, Morinaga A, Yugawa K
Hepatol Commun. 2021; 6(4):665-678.
PMID: 34687175
PMC: 8948647.
DOI: 10.1002/hep4.1838.
Impact and risk factors for skeletal muscle mass loss after hepatic resection in patients with hepatocellular carcinoma.
Itoh S, Yoshizumi T, Tomiyama T, Iseda N, Morinaga A, Shimagaki T
JGH Open. 2021; 5(7):785-792.
PMID: 34263073
PMC: 8264232.
DOI: 10.1002/jgh3.12588.
Lymphocyte-to-C-reactive protein ratio as a prognostic factor for hepatocellular carcinoma.
Iseda N, Itoh S, Yoshizumi T, Tomiyama T, Morinaga A, Shimagaki T
Int J Clin Oncol. 2021; 26(10):1890-1900.
PMID: 34251555
DOI: 10.1007/s10147-021-01985-x.
Prognostic significance of systemic inflammation score in patients who undergo hepatic resection for hepatocellular carcinoma.
Inokuchi S, Itoh S, Yoshizumi T, Morinaga A, Toshima T, Takeishi K
Langenbecks Arch Surg. 2021; 406(3):773-779.
PMID: 33595705
DOI: 10.1007/s00423-021-02103-1.
Assessment of remnant liver function and volume after selective ligation of portal vein and hepatic artery in a rat model.
Abreu T, Ribeiro A, Provenzano L, Ribeiro Filho J, Schanaider A
Acta Cir Bras. 2020; 34(11):e201901103.
PMID: 31939502
PMC: 6956645.
DOI: 10.1590/s0102-865020190110000003.
Prognostic significance of inflammatory biomarkers in hepatocellular carcinoma following hepatic resection.
Itoh S, Yugawa K, Shimokawa M, Yoshiya S, Mano Y, Takeishi K
BJS Open. 2019; 3(4):500-508.
PMID: 31388642
PMC: 6677099.
DOI: 10.1002/bjs5.50170.
Slow Gait Speed Is a Risk Factor for Complications After Hepatic Resection.
Itoh S, Yoshizumi T, Sakata K, Motomura T, Mano Y, Toshima T
J Gastrointest Surg. 2018; 23(9):1810-1816.
PMID: 30298420
DOI: 10.1007/s11605-018-3993-5.
Pleural Effusion After Hepatectomy for Hepatocellular Carcinoma: Risk Factor Analyses and Its Impact on Oncological Outcomes.
Uchiyama H, Harimoto N, Itoh S, Yoshizumi T, Ikegami T, Maehara Y
World J Surg. 2016; 41(4):1089-1099.
PMID: 27882419
DOI: 10.1007/s00268-016-3826-1.
Central hepatectomy for centrally located malignant liver tumors: A systematic review.
Lee S
World J Hepatol. 2014; 6(5):347-57.
PMID: 24868328
PMC: 4033292.
DOI: 10.4254/wjh.v6.i5.347.
Treatment strategy to improve long-term survival for hepatocellular carcinoma smaller than 5 cm: major hepatectomy vs minor hepatectomy.
Wong T, Cheung T, Chok K, Chan A, Dai W, Chan S
World J Surg. 2014; 38(9):2386-94.
PMID: 24831671
DOI: 10.1007/s00268-014-2601-4.
Liver volumetry: Is imaging reliable? Personal experience and review of the literature.
DOnofrio M, De Robertis R, Demozzi E, Crosara S, Canestrini S, Mucelli R
World J Radiol. 2014; 6(4):62-71.
PMID: 24778768
PMC: 4000610.
DOI: 10.4329/wjr.v6.i4.62.
Recent trends in hepatectomy for elderly patients with hepatocellular carcinoma.
Ueno M, Hayami S, Tani M, Kawai M, Hirono S, Yamaue H
Surg Today. 2013; 44(9):1651-9.
PMID: 24091862
DOI: 10.1007/s00595-013-0739-6.
Multidisciplinary treatments for hepatocellular carcinoma with major portal vein tumor thrombus.
Katagiri S, Yamamoto M
Surg Today. 2013; 44(2):219-26.
PMID: 23591833
PMC: 3898334.
DOI: 10.1007/s00595-013-0585-6.